Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys

Parasite Immunology

Volumn 19, Issue 4, 1997, Pages 161-170

  Herrera, Sócrates ^a,b   De Plata, Cecilia ^a   González, J Mario ^a   Perlaza, Blanca Liliana ^a   Bettens, Florence ^c   Corradin, Giampietro ^b   Arévalo Herrera, Myriam ^a  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

CS protein; Malaria vaccine; MAP; T cell

Indexed keywords

GAMMA INTERFERON; MALARIA VACCINE; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MALARIA; MONKEY; NONHUMAN; PLASMID; PLASMODIUM VIVAX; PRIORITY JOURNAL;

EID: 0030939515     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1997.d01-193.x     Document Type: Article

References (39)

1. Arnot D., Barnwell J.W. & Steward M.J. (1988) Does biased gene conversion influence polymorphism in the circumsporozoite protein-encoding gene of Plasmodium vivax? Proceedings of the National Academy of Sciences, USA 85, 8102-8106
2. Atherton E., Loga C.J. & Sheppard R.C. (1988) Peptide synthesis. II. Procedures for solid phase synthesis using N α-fluorenymethoxycarbamilamino-acids on polyamide synthesis of substance P and of acyl-carrier protein 65-74 decapeptide. Journal of the Chemical Society Perkins Transaction 1, 538-548
3. Ballou W.R., Hoffman S.L., Sherwood S.A. et al. (1987) Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet i, 1277-1281
4. Charoenvit Y., Collins W.E., Jones T. et al. (1991) Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 251, 668-671
5. Clyde D.F., McCarthy V.C., Miller R.M. et al. (1975) Immunization of man against Plasmodium falciparum and vivax by use of attenuated sporozoites. American Journal of Tropical Medicine and Hygiene 24, 397-401
6. Currier, J., Sattabongkot J. & Good, M. (1992) 'Natural' T cells for malaria: evidence of highly sensitive malaria-specific responses from non-exposed donors. International Immunology 4, 985-994
7. Del Giudice G., Grillot D., Rénia L. et al. (1990) Peptide-primed CD4+ cells and malaria sporozoites. Immunology Letters 25, 59-63
8. Demotz S., Matricardi P., Lanzavecchia A. et al. (1989) A novel and simple procedure for determining T cell epitopes in protein antigens. Journal of Immunological Methods 122, 67-72
9. Egan J.E., Weber J.L., Ballou W.R. et al. (1987) Efficacy of murine malaria sporozoite vaccines: Implication for human vaccine development. Science 236, 435-456
10. Franke E., Lucas C.M., Chauca G. et al. (1992) Antibody response to the circumsporozoite protein of Plasmodium vivax in naturally infected humans. American Tropical Medicine & Hygiene 43, 320-326
11. Gao, X., M. Fernandez-Vina, Shumway W. et al. (1990) DNA typing for class II HLA antigens with allele-specific or group-specific amplification. Typing for subsets of HLA-DR4. Human of Immunology 27, 40-45
12. Gallati, H., I. Pracht., J. Schmidt, et al. (1987) A simple, rapid and large capacity ELISA for biologically active and recombinant human IFN-γ. Journal of Biology Regulation and Homeostatic Agents 1, 109-118
13. Herrera M.A., Rosero F., Herrera S. et al. (1992) Protection against malaria in Aotus monkeys immunized with a recombinant blood-stages antigen fused to an universal T-cell epitope: Correlation of serum-Interferon levels with protection. Infection and Immunity 60, 154-158
14. Herrera S., Escobar P., De Plata C. et al. (1992) Human recognition of T-cell epitopes on the Plasmodium vivax circumsporozoite protein. Journal of Immunology 48, 3986-3990
15. Herrera M.A., De Plata C., Gonzalez J.M. et al. (1994) Immunogenicity of Multiple Antigen Peptides (MAPs) containing Plasmodium vivax epitopes in BALB/c mice. Memorias do Instituto Oswaldo Cruz 89, 69-73
16. Herrington D.A., Clyde D.F., Losonsky G. et al. (1987) Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoite. Nature 328, 257-25
17. Hollingdale M.R., Nardin E.H., Tharavany S. et al. (1984) Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells, an in vitro assay of protective antibodies. Journal of Immunology 132, 909-913
18. Khusmith S., Charoenvit Y., Kumar S., Sedegah, M. et al. (1991) Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252, 715-718
19. Kumar S., Miller L.H., Quakyi I.A. et al. (1988) Cytotoxic T cell specific for the circumsporozoite protein of Plasmodium falciparum. Nature 334, 258-260
20. López J.A., González J.M., Kettner A. et al. (1997) Synthetic peptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: human T-cell recognition and immunogenicity in owl monkeys. Annals of Tropical Medicine and Parasitology (in press)
21. Mann V.H., Huang, T., Cheng Q. et al. (1994) Sequence variation in the circumsporozoite protein gene of Plasmodium vivax appears to be regionally biased. Molecular Biochemical Parasitology 68, 45-52
22. McCarthy V.C. & Clayde D.F. (1977) Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man. Experimental Parasitology 41, 167-171
23. Migliorini P., Betschart B. & Corradin, G. (1993) Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity. European Journal of Immunology 23, 582-585
24. Munesinghe D.Y., Clavijo P., Calvo-Calle J.M. et al. (1991) Antigenicity of multiple antigen peptides (MAP) containing B and T cell epitopes from the central repeat region of the P. falciparum circumsporozoite protein European Journal of Immunology 21, 3015-3020
25. Nussenzweig R., Vanderberg J. & Most, H. (1967) Protective immunity produced by the injection of x-irradiated sporozoite of Plasmodium berghei. Nature 216, 160-162
26. Panina-Bordignon P., Tam A., Termijtelen A. et al. (1989) Universally immunogenic T cell epitopes; promiscuous binding to human class II and promiscuous recognition by T cells. European Journal of Immunology 19, 2237-2242
27. Potocnjak P., Yoshida N., Nussenzweig R.S. et al. (1980) Monovalent fragments (Fab) of monoclonal antibodies to a sporozoile surface antigen (Pb44) protect mice against malaria infection. Journal of Experimental Medicine 151, 1504-1513
28. Romero P., Maryanski J.L., Corradin G. et al. (1989) Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341, 323
29. Rosenberg R., Wirtz R.A., Lanar D. et al. (1989) Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science 245, 973-976
30. Schofield L., Ferreira A., Altszuler R. et al. (1987) Interferon-gamma inhibits the intrahepatocytic development of malaria parasite in vitro. Journal of Immunology 139, 2020-2023
31. Sedegah M., Finkelman F. & Hoffman S. (1994) Interleukin 12 induction of interferon γ-dependent protection against malaria. Proceedings of the National Academy of Sciences, USA, 91, 10700-10702
32. Sinigaglia F., Guttinger M., Kilgus J. et al. (1988) A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 336, 778-780
33. Stevenson M., Tam M.F., Stanley F.W. et al (1995) IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. Journal of Immunology 155, 2545-2556.
34. Tam J.P. (1988) Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigen system. Proceedings of the National Academy of Sciences, USA 85, 5409-5413
35. Tam J.P., Clavijo P., Lu Y.A. et al. (1990) Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. Journal Experimental Medicine 171, 299-306
36. Valmori D., Pessi A., Bianchi E. et al. (1992) Use of human universally antigenic tetanus toxin T-cell epitopes as carriers for human vaccination. Journal of Immunology 149, 717-721
37. Wang R., Charoenvit Y., Corradin G. et al. (1995) Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. Journal of Immunology 154, 2784-2793
38. Weiss W.A., Mellouk S., Houghten R.A. et al. (1990) Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria infected hepatocytes. Journal Experimental Medicine 171, 763-773
39. + T cell (cytotoxic/supressors) are required for protection in mice immunized with malaria sporozoites. Proceedings of the National Academy of Sciences, USA 85, 573-576